This site is intended for Healthcare Professionals only

Suicide inquest finds A&E doctor did not provide sertraline advice

Suicide inquest finds A&E doctor did not provide sertraline advice

A coroner has raised concerns around a London NHS trust’s approach to emergency mental health assessments and medication advice following an inquest into the death by suicide of a 27-year-old woman who had complained of side effects from her recently commenced sertraline.

In a report to prevent future deaths, Mary Hassell, senior coroner for inner north London, found that the woman – who is not named in the report – presented at Whittington Hospital’s emergency department on March 27, 2026 complaining of side effects from recently prescribed sertraline.

The coroner wrote that the woman had “undergone an episode of screaming and sobbing” earlier that evening and said she was in a great deal of pain. Her “very concerned” flatmates took her to the hospital, where she was diagnosed with anxiety, depression and insomnia.

At 9am on April 1, 2026, the woman jumped from her flat while suffering “an episode of significant mental ill health,” wrote Ms Hassell. The woman died from a brain injury two days later.

The coroner found that the emergency department doctor who saw the woman advised her to see her GP for a medication review but did not advise her whether she could continue taking her prescribed sertraline, and did not “identify any features requiring emergency assessment by the mental health team”.

The report was issued to Whittington Health NHS Trust, which replied on November 12 stating that the trust’s internal review following the incident found that the woman “had been appropriately triaged and had undergone a clear and documented clinical assessment, including consideration of her mental health symptoms and immediate risk”.

It found that the threshold for an emergency referral “had not been met” at the time she presented at the emergency department.

However, the review “also identified opportunities for more detailed exploration of her reported behavioural disturbance, significant insomnia and recent commencement of sertraline,” the trust’s chief medical officer said.

The CMO said a “more detailed exploration” of the woman’s symptoms and circumstances “may have provided a fuller understanding of her changing mental state and any additional risk or support needs,” adding that it had been noted “that there was no documentation of any collateral history from [the woman’s] flatmate, which may have provided additional information to inform the clinical assessment”.

The CMO added: “The trust recognises the importance of providing clear medication advice, particularly where a patient presents with symptoms potentially associated with recently commenced psychotropic medication.

“This case has reinforced the need to ensure that decisions regarding continuation or review of medication, the rationale for those decisions and the urgency of follow-up are clearly communicated and documented.

“This learning has been incorporated into the planned Emergency Department teaching programme.”

The CMO said the trust is committed to implementing these learnings into its approach to treating patients with mental health concerns.

Related: Warnings about ofloxacin risk provide ‘insufficient safeguards’, says coroner after suicide

‘No guidance’ for drug administration timelines in mental health crises, finds coroner

Share:

Change privacy settings